These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 667444)

  • 1. A 16-p-fluorophenoxy prostanoid with potent and long-lasting thromboxane-like actions [proceedings].
    Jones RL; Wilson NH
    Br J Pharmacol; 1978 Jun; 63(2):362P. PubMed ID: 667444
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 3. PGD3 is the mediator of the antiaggregatory effects of the trienoic endoperoxide PGH3.
    Whitaker MO; Needleman P; Wyche A; Fitzpatrick FA; Sprecher H
    Adv Prostaglandin Thromboxane Res; 1980; 6():301-3. PubMed ID: 6966885
    [No Abstract]   [Full Text] [Related]  

  • 4. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2.
    Svensson J
    Acta Biol Med Ger; 1978; 37(5-6):731-40. PubMed ID: 742285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoquinol selectively antagonises longitudinal muscle contractions of rat isolated gastric fundus to thromboxane B2 and epoxymethano analogues of PGH2 [proceedings].
    Bennett A; Sanger GJ
    Br J Pharmacol; 1979 Jul; 66(3):450P. PubMed ID: 526738
    [No Abstract]   [Full Text] [Related]  

  • 7. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
    Varfolomeev SD; Lakin KM; Mevkh AT; Novikova NV; Rukazenkov IuZ
    Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological effects of 15-hydroperoxythromboxane A2 on platelets and aorta.
    Hammarström S
    Prostaglandins Med; 1980 May; 4(5):297-302. PubMed ID: 7403329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoconstrictor response of arterioles of the hamster cheek pouch to norepinephrine, prostaglandin H2, F2 alpha and carbocyclic thromboxane A2, a possible thromboxane A2 analogue.
    Herrmann KS
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):180-5. PubMed ID: 6960809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins and thromboxanes: biochemical and physiological considerations.
    Samuelsson B; Folco G; Granström E; Kindahl H; Malmsten C
    Adv Prostaglandin Thromboxane Res; 1978; 4():1-25. PubMed ID: 347910
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of human lymph contractility by prostaglandins and thromboxane.
    Sinzinger H; Kaliman J; Mannheimer E
    Lymphology; 1984 Jun; 17(2):43-5. PubMed ID: 6381904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lymphatic contractility by arachidonate metabolites.
    Johnston MG; Gordon JL
    Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1982 Jul; 222(1):276-81. PubMed ID: 7086705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGH2, TxA2 and PGI2 have potent and differentiated actions on human uterine contractility.
    Wilhelmsson L; Wikland M; Wiqvist N
    Prostaglandins; 1981 Feb; 21(2):277-86. PubMed ID: 7012935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting prostaglandin endoperoxide transformation: antibodies against PGH2.
    Fitzpatrick FA; Pike JE
    Prog Lipid Res; 1981; 20():179-82. PubMed ID: 7342082
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current state of our knowledge about prostaglandins].
    Markov KhM
    Patol Fiziol Eksp Ter; 1979; (5):3-15. PubMed ID: 228228
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of precursors, products, and product analogs of prostaglandin cyclooxygenase upon iris sphincter muscle.
    Crawford CG; van Alphen GW; Cook HW; Lands WE
    Life Sci; 1978 Sep; 23(12):1255-62. PubMed ID: 101727
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogues of arachidonic acid used to evaluate structural determinants of prostaglandin receptor and enzyme specificities.
    LeDuc LE; Wyche AA; Sprecher H; Sankarappe SK; Needleman P
    Mol Pharmacol; 1981 Mar; 19(2):242-7. PubMed ID: 6262618
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
    Rettkowski W; Pönicke K; Block HU; Giessler C; Dunemann A; Zehl U; Förster W
    Arzneimittelforschung; 1982; 32(3):194-200. PubMed ID: 6805480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.